Red Queen Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$55M
- Investors
-
1
Red Queen General Information
Description
Developer of biotechnology drugs intended to prepare rapid responses to current and emerging pathogens that threaten human health and life. The company operates a novel plug-and-play antiviral platform based on stapled peptide decoys, which can be rapidly deployed against pandemic and pandemic-potential viruses, as well as other viruses that cause recurring, untreated disease, helping users to protect themselves from viruses and infections entering the body.
Contact Information
Website
www.redqueentx.comCorporate Office
- 245 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 245 Main Street
- Cambridge, MA 02139
- United States
Red Queen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 06-Aug-2024 | $55M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | 07-Oct-2021 | Completed | Startup |
Red Queen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Red Queen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Red Queen Patents
Red Queen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025235945-A1 | Methods of treating viral infections using a fusion inhibitor | Pending | 10-May-2024 | ||
| EP-4815982-A2 | Antiviral structurally stapled herpesviridae peptides and uses thereof | Pending | 28-Nov-2023 | ||
| WO-2025117649-A2 | Antiviral structurally stapled herpesviridae peptides and uses thereof | Inactive | 28-Nov-2023 | ||
| WO-2025117649-A3 | Antiviral structurally stapled herpesviridae peptides and uses thereof | Inactive | 28-Nov-2023 | ||
| AU-2024380301-A1 | Antiviral structurally stapled influenza peptides and uses thereof | Pending | 15-Nov-2023 | C07K14/005 |
Red Queen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Red Queen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apple Tree Partners (ATP) | Venture Capital | Minority |
Red Queen FAQs
-
When was Red Queen founded?
Red Queen was founded in 2021.
-
Where is Red Queen headquartered?
Red Queen is headquartered in Cambridge, MA.
-
What is the size of Red Queen?
Red Queen has 3 total employees.
-
What industry is Red Queen in?
Red Queen’s primary industry is Drug Delivery.
-
Is Red Queen a private or public company?
Red Queen is a Private company.
-
What is Red Queen’s current revenue?
The current revenue for Red Queen is .
-
How much funding has Red Queen raised over time?
Red Queen has raised $60M.
-
Who are Red Queen’s investors?
Apple Tree Partners (ATP) has invested in Red Queen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
